Stockreport

Calidi Biotherapeutics Announces Partnership with Avance Clinical to Facilitate Australian Regulatory Approval and Accelerate Initiation of CLD-401 Clinical Trials [Yahoo! Finance]

Calidi Biotherapeutics, Inc.  (CLDI) 
PDF the “Company”), a biotechnology company pioneering the development of targeted genetic medicines, today announced a partnership with Avance Clinical, a full-service cont [Read more]